Gumus, E. Et Al. 2016. Possible role of asymmetric dimethylarginine (ADMA) in prediction of perinatal outcome in preeclampsia and fetal growth retardation related to preeclampsia. JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE , no.23 , 3806-3811.

Gumus, E., Atalay, M. A., Demir, B., & Gunes, E. S., (2016). Possible role of asymmetric dimethylarginine (ADMA) in prediction of perinatal outcome in preeclampsia and fetal growth retardation related to preeclampsia. JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE , no.23, 3806-3811.

Gumus, Ertac Et Al. "Possible role of asymmetric dimethylarginine (ADMA) in prediction of perinatal outcome in preeclampsia and fetal growth retardation related to preeclampsia," JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE , no.23, 3806-3811, 2016

Gumus, Ertac Et Al. "Possible role of asymmetric dimethylarginine (ADMA) in prediction of perinatal outcome in preeclampsia and fetal growth retardation related to preeclampsia." JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE , no.23, pp.3806-3811, 2016

Gumus, E. Et Al. (2016) . "Possible role of asymmetric dimethylarginine (ADMA) in prediction of perinatal outcome in preeclampsia and fetal growth retardation related to preeclampsia." JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE , no.23, pp.3806-3811.

@article{article, author={Ertac Gumus Et Al. }, title={Possible role of asymmetric dimethylarginine (ADMA) in prediction of perinatal outcome in preeclampsia and fetal growth retardation related to preeclampsia}, journal={JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE}, year=2016, pages={3806-3811} }